In this issue, we’re taking a look at a handful of new investigations into whether certain companies can be held accountable for how they market their products and (fail to) protect our personal information. To start, attorneys working with ClassAction.org are investigating whether BetMGM put adequate data security measures in place to keep user information safe from hackers. They’re also looking into whether a class action lawsuit can be filed following reports that UCLA Health notified thousands of patients of a data privacy issue stemming from the use of analytics tools on the healthcare provider’s website and app.
As far as consumer products go, attorneys are also investigating a few popular tampon brands for possibly using harmful chemicals known as PFAS and certain 5-HTP manufacturers for marketing what could be an unsafe drug as a dietary supplement.
We’ll wrap up this week with new settlements that you may be able to claim, so keep reading for the latest.
If you received a notice from BetMGM that your information may have been compromised in a recent data breach, attorneys working with ClassAction.org would like to hear from you. They have reason to believe that BetMGM, which operates online casino and sports betting platforms including BetMGM.com, Borgata Online, PartyCasino and PartyPoker, may have failed to put adequate data security measures in place to keep users’ information safe prior to the breach. Now, the attorneys are gathering BetMGM users together to potentially take action against the company via mass arbitration. Mass arbitration is different from a class action lawsuit and often requires more consumers to come forward in order to be successful. While there are no guarantees, those who sign up for the mass arbitration may be entitled to $200 or more. So, if you received a data breach notice from BetMGM, head over to this page to learn more about your rights and join others taking action.
If you received a notice in or around January 2023 stating that you may have been affected by a data privacy issue related to the use of analytics tools on UCLA Health’s website or mobile app, you aren’t alone. On January 13, UCLA Health announced that certain information from appointment request forms completed on UCLAHealth.org and its related mobile app may have been captured and transmitted to third-party service providers – a problem that’s reportedly affected approximately 94,000 individuals. Now, it’s being investigated whether a class action lawsuit can be filed on behalf of patients who were affected by the data issue. Potentially, a class action lawsuit could hold UCLA Health accountable for the problem and force the healthcare provider to take certain steps to help ensure information submitted online is kept private and confidential. If you received a notice from UCLA Health in January 2023 about an online data sharing issue, head on over to this page and tell us about it.
Our settlements page is always being updated. Have you checked to see if you're covered by any open settlements? You can also check out the latest settlements as they happen by following us on Twitter.
Certain tampons sold under the Tampax, o.b. and Playtex brand names, as well as one Always pad product, are under scrutiny as attorneys have reason to suspect that they may contain toxic chemicals known as per-and polyfluoroalkyl substances (PFAS). Now, the attorneys are looking into whether class action lawsuits can be filed over the way the products were advertised to consumers. PFAS are commonly referred to as “forever chemicals” because of their inability to break down in the environment and their persistence in the human body, and the Environmental Protection Agency has associated exposure to the chemicals with a slew of health problems. If filed and successful, a class action lawsuit could help consumers get back some of the money they paid for the products and force the companies to change their advertising or manufacturing practices. Want to learn more? Head over to this page for the specific list of products under investigation and a chance to help get a class action started.
Attorneys working with ClassAction.org would like to speak with anyone who has purchased 5-HTP, a supplement that claims to help with mood and sleeplessness. Though some manufacturers are selling 5-HTP products as dietary supplements – which are not regulated by the FDA – the attorneys have reason to believe that the chemical is more complex than most people realize and should actually be classified as a drug. If 5-HTP is actually a drug being illegally marketed as a run-of-the-mill supplement, consumers may be taking something that would normally require a doctor’s guidance while falsely believing that it has no serious interactions or side effects because it’s sold over the counter. Attorneys are now investigating the situation and are looking into whether lawsuits can be filed to hold the manufacturers accountable. Want more? You can read up on the details here.
~ Forward to a friend ~
Know someone who might be interested in our newsletter? Why not forward this email to them?